450 Interim report on a phase I/IIA, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in Chinese patients with chronic hepatitis B infection

✍ Scribed by M.F. Yuen; J. Kim; D.K.H. Wong; V.W.S. Ngai; J.C.H. Yuen; C.L. Lai

• Book ID: 117373279
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 69 KB
• Volume: 40
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(04)90450-3